Home > Balance Sheet > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Balance Sheet

ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year Balance Sheet History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
EQUITY AND LIABILITIES
Share Capital ₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr
    Equity - Authorised ₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr
    Equity - Issued ₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr
    Equity Paid Up ₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr₹5.00 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹2.00₹2.00₹2.00₹2.00₹2.00
Share Warrants & Outstandings ₹3.29 Cr₹2.57 Cr₹1.95 Cr₹1.59 Cr₹1.59 Cr
Total Reserves ₹704 Cr₹581 Cr₹504 Cr₹450 Cr₹358 Cr
    Securities Premium -----
    Capital Reserves ₹72 Cr₹72 Cr₹72 Cr₹72 Cr₹72 Cr
    Profit & Loss Account Balance ₹578 Cr₹456 Cr₹379 Cr₹324 Cr₹232 Cr
    General Reserves ₹53 Cr₹53 Cr₹53 Cr₹53 Cr₹53 Cr
    Other Reserves -----
Reserve excluding Revaluation Reserve ₹704 Cr₹581 Cr₹504 Cr₹450 Cr₹358 Cr
Revaluation reserve -----
Shareholder's Funds ₹712 Cr₹589 Cr₹511 Cr₹456 Cr₹364 Cr
Minority Interest -----
Long-Term Borrowings -----
Secured Loans -----
    Non Convertible Debentures -----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks -----
    Term Loans - Institutions -----
    Other Secured -----
Unsecured Loans -----
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes -----
    Long Term Loan in Foreign Currency -----
    Loans - Banks -----
    Loans - Govt. -----
    Loans - Others -----
    Other Unsecured Loan -----
Deferred Tax Assets / Liabilities ₹-21 Cr₹-21 Cr₹-16 Cr₹-15 Cr₹-15 Cr
    Deferred Tax Assets ₹22 Cr₹22 Cr₹18 Cr₹17 Cr₹17 Cr
    Deferred Tax Liability ₹1.06 Cr₹1.53 Cr₹1.87 Cr₹2.78 Cr₹2.83 Cr
Other Long Term Liabilities ₹2.78 Cr₹3.69 Cr₹5.02 Cr₹8.63 Cr₹9.30 Cr
Long Term Trade Payables -----
Long Term Provisions ₹116 Cr₹86 Cr₹85 Cr₹51 Cr₹49 Cr
Total Non-Current Liabilities ₹98 Cr₹69 Cr₹74 Cr₹45 Cr₹44 Cr
Current Liabilities -----
Trade Payables ₹197 Cr₹228 Cr₹190 Cr₹178 Cr₹210 Cr
    Sundry Creditors ₹197 Cr₹228 Cr₹190 Cr₹178 Cr₹210 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹111 Cr₹112 Cr₹94 Cr₹83 Cr₹71 Cr
    Bank Overdraft / Short term credit -----
    Advances received from customers -----
    Interest Accrued But Not Due -----
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹111 Cr₹112 Cr₹94 Cr₹83 Cr₹71 Cr
Short Term Borrowings -----
    Secured ST Loans repayable on Demands -----
    Working Capital Loans- Sec -----
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans -----
Short Term Provisions ₹160 Cr₹145 Cr₹108 Cr₹112 Cr₹86 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹121 Cr₹107 Cr₹69 Cr₹80 Cr₹46 Cr
    Provision for post retirement benefits ₹1.06 Cr₹0.63 Cr₹0.54 Cr₹0.50 Cr₹5.44 Cr
    Preference Dividend -----
    Other Provisions ₹38 Cr₹37 Cr₹38 Cr₹32 Cr₹35 Cr
Total Current Liabilities ₹467 Cr₹484 Cr₹392 Cr₹373 Cr₹367 Cr
Total Liabilities ₹1,277 Cr₹1,142 Cr₹977 Cr₹874 Cr₹776 Cr
ASSETS
Gross Block ₹187 Cr₹179 Cr₹169 Cr₹160 Cr₹133 Cr
Less: Accumulated Depreciation ₹120 Cr₹110 Cr₹94 Cr₹79 Cr₹61 Cr
Less: Impairment of Assets -----
Net Block ₹67 Cr₹69 Cr₹74 Cr₹81 Cr₹72 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹0.27 Cr₹1.33 Cr₹2.20 Cr₹4.02 Cr₹24 Cr
Non Current Investments -----
Long Term Investment -----
    Quoted -----
    Unquoted -----
Long Term Loans & Advances ₹167 Cr₹136 Cr₹135 Cr₹101 Cr₹98 Cr
Other Non Current Assets ---₹0.01 Cr₹0.01 Cr
Total Non-Current Assets ₹234 Cr₹206 Cr₹212 Cr₹186 Cr₹193 Cr
Current Assets Loans & Advances -----
Currents Investments -----
    Quoted -----
    Unquoted -----
Inventories ₹228 Cr₹190 Cr₹140 Cr₹160 Cr₹165 Cr
    Raw Materials ₹18 Cr₹15 Cr₹14 Cr₹20 Cr₹21 Cr
    Work-in Progress ₹4.73 Cr₹1.67 Cr₹3.06 Cr₹3.74 Cr₹1.22 Cr
    Finished Goods ₹44 Cr₹37 Cr₹39 Cr₹33 Cr₹23 Cr
    Packing Materials ₹1.34 Cr₹1.51 Cr₹1.76 Cr₹2.14 Cr₹2.39 Cr
    Stores  and Spare ₹1.74 Cr₹1.72 Cr₹1.77 Cr₹1.78 Cr₹1.60 Cr
    Other Inventory ₹158 Cr₹133 Cr₹81 Cr₹100 Cr₹116 Cr
Sundry Debtors ₹153 Cr₹108 Cr₹86 Cr₹85 Cr₹83 Cr
    Debtors more than Six months ₹15 Cr₹9.64 Cr₹10 Cr₹6.81 Cr-
    Debtors Others ₹160 Cr₹115 Cr₹91 Cr₹89 Cr₹92 Cr
Cash and Bank ₹506 Cr₹500 Cr₹448 Cr₹352 Cr₹253 Cr
    Cash in hand -----
    Balances at Bank ₹506 Cr₹500 Cr₹448 Cr₹352 Cr₹253 Cr
    Other cash and bank balances -----
Other Current Assets ₹13 Cr₹14 Cr₹13 Cr₹9.84 Cr₹10 Cr
    Interest accrued on Investments ₹2.27 Cr₹1.79 Cr₹1.82 Cr₹1.45 Cr₹1.84 Cr
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹11 Cr₹12 Cr₹11 Cr₹8.39 Cr₹8.28 Cr
    Other current_assets -----
Short Term Loans and Advances ₹143 Cr₹124 Cr₹78 Cr₹82 Cr₹71 Cr
    Advances recoverable in cash or in kind ₹1.01 Cr₹0.65 Cr₹1.27 Cr₹0.55 Cr₹1.29 Cr
    Advance income tax and TDS ₹110 Cr₹100 Cr₹60 Cr₹70 Cr₹40 Cr
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹32 Cr₹23 Cr₹17 Cr₹11 Cr₹30 Cr
Total Current Assets ₹1,043 Cr₹936 Cr₹765 Cr₹689 Cr₹582 Cr
Net Current Assets (Including Current Investments) ₹576 Cr₹452 Cr₹373 Cr₹315 Cr₹215 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹1,277 Cr₹1,142 Cr₹977 Cr₹874 Cr₹776 Cr
Contingent Liabilities ₹138 Cr₹132 Cr₹123 Cr₹86 Cr₹67 Cr
Total Debt -----
Book Value 283.45234.45203.78181.83145.14
Adjusted Book Value 283.45234.45203.78181.83145.14

Compare Balance Sheet of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹15,938.6 Cr -1.9% -1.9% 19.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-1.9%

-1.9%

19.3%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses